Issue 63, 2019, Issue in Progress

Injectable drug-loaded polysaccharide hybrid hydrogels for hemostasis

Abstract

An injectable hydrogel with high adhesion strength, non-toxicity and low cost is highly desired for developing highly efficient hemostasis. In this study, we developed a new type of injectable adhesive drug loaded hydrogel utilizing the formation of Schiff-base linkages based on carboxymethyl chitosan (CMC), gelatin (GEL) and oxidized alginate (OSA). By optimizing the concentration of the biopolymers, the hybrid hydrogel (CMC-GEL/OSA) demonstrated an extremely fast gelation rate (30 s) and adhesive strength of 11 kPa. The freeze-dried hydrogel showed a three-dimensional porous structure. The hydrogel loaded with levofloxacin exhibited good antibacterial properties. Hemostatic performance of the hydrogel was demonstrated in a rat liver injury model. Compared with the untreated wound, the hemostasis time of the hydrogel treated wound was shortened by 84.2% and the blood loss was reduced by 82.2%. Thus, the proposed injectable hydrogel holds great potential applications for hemostasis, drug delivery and in other biomedical fields.

Graphical abstract: Injectable drug-loaded polysaccharide hybrid hydrogels for hemostasis

Article information

Article type
Paper
Submitted
05 Sep 2019
Accepted
02 Nov 2019
First published
12 Nov 2019
This article is Open Access
Creative Commons BY license

RSC Adv., 2019,9, 36858-36866

Injectable drug-loaded polysaccharide hybrid hydrogels for hemostasis

J. Cao, L. Xiao and X. Shi, RSC Adv., 2019, 9, 36858 DOI: 10.1039/C9RA07116D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements